References

  1. Innocenti M et al. J Pain Symptom Manage 2002; 24(5): 456–457.
  2. Berndtson M. Svensk Sjukhustandlakartidning [Swedish Hospital Dentistry] 2001; 26(3): 17–21.
  3. De Cordi D et al. Abstract presented at 3rd Italian Anti-Tumour League Congress of Professional Oncology Nurses, Conegliano, Italy. October 2001.
  4. Bonassi L et al. Ann Oncol 2001.
  5. D’Andrea et al. Ann Oncol 2003.
  6. Wildfang et al. J Clin Oncol 2016.
  7. Flook C et al. Support Care Cancer 2005.
  8. Lindsay et al. Australia Nursing J 2009.
  9. McLean M Poster presented at the British Association of Head and Neck Oncology Nurses National Study Day on Sharing Good Practice in Head and Neck Cancer Nursing, 2009.
  10. Silverman S. J Support Oncol 2007; 5(2 Suppl 1): 13–21.
  11. Sonis S et al. Cancer 2004; 100(9 Suppl): 1995–2025.
  12. Elting L et al. Cancer 2003; 98(7): 1531–1539.
  13. Epstein J, Schubert M. Oncology (Williston Park) 2003; 17(12): 1767–1779.
  14. Elting L et al. Int J Radiat Oncol Biol Phys 2007; 68(4): 1110–1120.
  15. Smith T. Hosp Med 2001; 62(10): 623–626.
  16. National Cancer Institute. Oral Complications of Chemotherapy and Head/Neck Radiation (PDQ®). Available at: www.cancer.gov [accessed March 2019].
  17. Keefe D et al. Cancer 2007; 109(5): 820–831.

You are now leaving the UK healthcare professionals section of the website.

You will be returned to the public section of the website.

Are you a health care professional?

This section of the website has been created to provide UK healthcare professionals with information regarding Gelclair®